Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors (NCT04551144) | Clinical Trial Compass
TerminatedNot Applicable
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
Stopped: lack of recruitment
United States4 participantsStarted 2020-10-06
Plain-language summary
The purpose of this research is to find out if hormone therapy in transgender subjects' changes hormone receptors in blood, muscle and fat; fat production; muscle production; and inflammation processes.
Who can participate
Age range18 Years – 50 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosed with gender incongruence by a mental health professional and willing to start gender affirming therapy
Exclusion Criteria:
* Used hormone therapy in last 6 months,
* Pregnancy,
* Planning to have biological children in the next one year,
* HIV Additional exclusion criteria for transmen: 1) hematocrit \>50% for transmen, 2) transmen with allergy to cottonseed oil (component of intramuscular testosterone injection), 3) uncompensated heart failure, 4) renal failure Additional exclusion criteria for transwomen: 1) allergy to castor oil (component of intramuscular estradiol injection), 2) Known or suspected estrogen-dependent neoplasia, 3) Active deep vein thrombosis, pulmonary embolism or a history of these conditions, 4) Active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction), 5) Liver enzymes (AST or ALT) \>3 times the upper limit of normal, 6) Known or suspected pregnancy